Top Pharmaceutical Companies in Hyderabad (27)
Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The predictive power of Schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries.
Schrödinger, Inc.'s Top Stability & Growth Strengths
Strong Revenue Growth: Total revenue increased to $255.9M in 2025 with software up and drug‑discovery more than doubling, while operating expenses declined year over year. Early 2026 also showed momentum, with first‑half revenue modestly higher and Q2 posting year‑over‑year growth.
Strategic Partnerships: New and expanded agreements—such as Bristol Myers Squibb deploying Bunsen and a July 2026 discovery collaboration with Simcere—broaden platform use and collaboration optionality. The Lilly/Ajax transaction also validated the model and supported a higher 2026 drug‑discovery outlook.
Product Line Growth: The introduction of Bunsen, an agentic AI co‑scientist, expands the software portfolio and is being deployed at scale within BMS. This product push complements growth in ACV and broader platform adoption.
Devsynthesis is a Discovery Chemistry CRO which offer Multi-step complex chemistry molecules under different business models like FFS and FTE. We are very strong in complex library synthesis and targeted Scaffolds. We have delivered important projects in timely manner. Additionally We have installed the new Bruker NMR and now we are fully equipped and able to speed up synthesis research...
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical...
Parexel's Top Stability & Growth Strengths
Strong Market Position & Advantage: Feedback suggests Parexel is consistently viewed as a top-tier, full-service CRO, reinforced by repeated industry awards and strong site collaboration recognition. These signals indicate competitive strength in winning and delivering complex global programs.
Strategic Partnerships: Feedback suggests multi-year collaborations to embed advanced analytics and AI (e.g., Palantir and other AI initiatives) are intended to improve trial efficiency and differentiation. Such partnerships underscore continued investment in modernization and execution.
Market Expansion: Feedback suggests the company opened a new global headquarters in Raleigh and continues to reference a 20,000+ to 24,000+ global workforce, indicating operational scaling. Physical expansion and ongoing hiring activity support broader delivery capacity across regions.
Aryastha Life Science shines as a beacon of innovation and leadership, illuminating the pharmaceutical and biotechnology sectors. We fearlessly address and deliver the intricate challenges within drug discovery and development with unwavering determination. Our foundation is built upon years of transformative experience, culminating in Aryastha's inception. Aryastha represents the culmination of dedicated efforts to overcome scientific barriers spanning various facets...
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Novartis's Top Stability & Growth Strengths
Strong Revenue Growth: Novartis shows multi-year sales expansion, with full-year results indicating continued top-line growth driven by priority brands across several therapeutic areas.
Profitability: Margins and operating income are described as strengthening, with core operating margin reaching about 40% alongside year-over-year core operating income growth.
Innovation-Driven Growth: Growth is supported by scaling priority brands and a deep pipeline with multiple high-value assets, alongside business development to add late- and mid-stage programs.
Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of patients with underserved conditions. As an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company’s patient-centric products span...
HTS Biopharma established in 2012 is a leading manufacturer and supplier of impurity Reference Standards as per Pharmacopeia, API reference standards, Process Impurity, Metabolite, Building blocks and Bio molecules. We also undertake custom synthesis and contract manufacturing.
We accelerate access to affordable and innovative medicines because Good Health Can’t Wait.
Viatris is a global pharmaceutical company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer.
Viatris's Top Stability & Growth Strengths
Cost & Operational Efficiency: Cost-savings efforts are positioned as a concrete lever to support improved earnings and fund growth priorities, with an enterprise-wide program targeting substantial savings over multiple years. Guidance frames these actions as part of a broader move toward sustained revenue and earnings improvement beginning in 2026.
Resilient & Sustainable Growth: Growth is presented as re-emerging, with management guiding to a return to modest year-over-year revenue expansion in 2026 after a softer 2025. Improving quarterly trends exiting 2025 and a baseline of modest operational growth excluding divestitures support a narrative of stabilization.
Strong Market Position & Advantage: Scale and global reach are repeatedly highlighted as a stabilizing advantage, with broad geographic coverage and a large portfolio supporting access, supply reach, and competitive standing in off-patent medicines. The strategic shift toward complex generics and specialty brands is framed as reinforcing the company’s long-term positioning against pricing pressures.
Discover how Excelra, a leader in biopharma data and analytics, uniquely blends scientific understanding with technological expertise. This dual mastery empowers innovative drug discovery and development, transforming research data into actionable insights for groundbreaking discovery. ?????????? ????????? ???? ????????? Excelra’s interdisciplinary approach combines life science expertise with cutting-edge technology. This leads to confident, data-centric decisions, simplifying your data-driven drug discovery journey and...
An Indian Pharmaceutical company promoted by Industry professionals to address the growing medical needs in the management of Diabetic Complications, Mitochondrial Abnormalities, Wound Care & Pain Management through quality medicines at affordable prices. Bion Therapeutics currently conducts operations in 13 Indian states, Telangana, Andhra Pradesh, Tamilnadu, Kerala, Karnataka, Odisha, West Bengal and the Seven North Eastern Sister States (Assam, Arunachal Pradesh,...
Established in 2017, We are a pure-play Active Pharmaceutical Ingredient (API) company keen on delivering superior products in a regulatory compliant environment. We are backed up with manufacturing facilities in India with a combined manufacturing capacity of 600 KL and our flagship facility in Hyderabad in approved with USFDA, EDQM, WHO Geneva, COFEPRIS, KFDA amongst other regulatory agencies. Our facilities, coupled...
ProPharma is the premier Research Consulting Organization (RCO), delivering fully customizable consulting solutions to empower biotech, med device, and pharmaceutical organizations of all sizes to advance scientific breakthroughs confidently and introduce new therapies. With over 20 years of expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma partners with clients across the...
Transforming Healthcare with Innovation Multiplier AI is a leading force in the Healthcare industry, providing cutting-edge solutions to global brands like Galderma, Abbott, Merck, Cipla, Mankind, and more. With a team of 70+ dedicated professionals, we specialize in Generative AI, data insights, and physician influencer marketing, driving growth and transformation in the Healthcare landscape. Our Expertise: Generative AI and Personalized...
Sigachi Industries Limited is a leading Public Listed (NSE & BSE in India) Healthcare company working in domains of Pharmaceutical API & Excipients, Food & Nutrition, and Operations & Management industries. Founded in 1989, we've built a reputation for Pharmaceutical excellence in: •API & Intermediates: Our diversified portfolio includes active pharmaceutical ingredients (APIs) and their intermediates, supporting the development of life-saving...
Suven Pharma is a contract drug development and manufacturing (CDMO) services partner, built on more than 35+ years of research, innovation, quality, and innovative technology capability.
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations...
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together...
Syneos Health's Top Stability & Growth Strengths
Strong Market Position & Advantage: Company materials and third‑party recognition portray a fully integrated CRO/CCO with leadership status, including widespread involvement in recent FDA/EMA novel therapies and recognition as a leading pharmacovigilance provider.
Strategic Partnerships: Recent collaborations with Microsoft and KX are positioned to enable AI‑driven efficiencies across clinical and commercial operations, with reported improvements in cycle times supporting operational scalability.
Investor Backing & Capital Strength: The 2025 take‑private by investment groups (including Elliott and Veritas) provides financial sponsorship to pursue tech‑enabled growth and operational repositioning.
Apollo Clinic is a subsidiary of Apollo Hospitals Enterprise, offering a wide range of medical services with that same trusted expertise and excellence. They aim to deliver quality healthcare of international standards to neighbourhoods across the country. Apollo Clinics are an integrated multi-speciality clinic that offers Specialist Consultation, Diagnostics, Preventive Health Checks and Pharmacy, all under one roof. With state-of-the-art...
Laurus labs is an innovation-driven¸ people-centric & client-focused organization offering a broad and integrated portfolio of products & services to the global pharmaceutical industry.
